Fig. 4From: Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation studySurvival difference among groups of below NLR 2.0, NLR 2 to 6 and ≥ NLR 6.0 in a validation cohort. a OS, b DFSBack to article page